End-of-day quote
Shanghai S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
5.12
CNY
|
+3.02%
|
|
+9.87%
|
-45.47%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
4,777
|
1,518
|
2,767
|
4,021
|
11,422
|
12,632
|
Enterprise Value (EV)
1 |
4,947
|
1,609
|
3,276
|
4,829
|
12,279
|
12,783
|
P/E ratio
|
-5.17
x
|
-3.7
x
|
134
x
|
119
x
|
369
x
|
1,526
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
157
x
|
-
|
13.9
x
|
3.73
x
|
8.19
x
|
9.25
x
|
EV / Revenue
|
162
x
|
-
|
16.4
x
|
4.48
x
|
8.81
x
|
9.36
x
|
EV / EBITDA
|
-5.85
x
|
-6.66
x
|
94
x
|
31.8
x
|
60.7
x
|
93.8
x
|
EV / FCF
|
13.5
x
|
6.12
x
|
71.8
x
|
-20.4
x
|
1,131
x
|
17.9
x
|
FCF Yield
|
7.4%
|
16.3%
|
1.39%
|
-4.89%
|
0.09%
|
5.58%
|
Price to Book
|
167
x
|
-3.98
x
|
78.7
x
|
60.2
x
|
117
x
|
119
x
|
Nbr of stocks (in thousands)
|
1,071,275
|
1,071,275
|
1,071,275
|
1,071,275
|
1,071,275
|
1,071,275
|
Reference price
2 |
5.450
|
1.720
|
3.260
|
5.050
|
14.44
|
15.87
|
Announcement Date
|
8/29/18
|
6/27/19
|
4/27/20
|
4/29/21
|
4/18/22
|
4/24/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
30.52
|
-
|
199.4
|
1,079
|
1,394
|
1,366
|
EBITDA
1 |
-845
|
-241.4
|
34.86
|
151.9
|
202.2
|
136.3
|
EBIT
1 |
-847
|
-242.6
|
24.4
|
76.83
|
122.2
|
60.7
|
Operating Margin
|
-2,775.24%
|
-
|
12.24%
|
7.12%
|
8.77%
|
4.44%
|
Earnings before Tax (EBT)
1 |
-1,127
|
-497.8
|
30.04
|
57.71
|
60.6
|
23.77
|
Net income
1 |
-1,129
|
-497.8
|
25.98
|
45.56
|
41.89
|
11.12
|
Net margin
|
-3,697.59%
|
-
|
13.03%
|
4.22%
|
3%
|
0.81%
|
EPS
2 |
-1.054
|
-0.4646
|
0.0243
|
0.0425
|
0.0391
|
0.0104
|
Free Cash Flow
1 |
366.3
|
262.8
|
45.62
|
-236.3
|
10.86
|
713.4
|
FCF margin
|
1,200.17%
|
-
|
22.88%
|
-21.9%
|
0.78%
|
52.23%
|
FCF Conversion (EBITDA)
|
-
|
-
|
130.88%
|
-
|
5.37%
|
523.25%
|
FCF Conversion (Net income)
|
-
|
-
|
175.58%
|
-
|
25.92%
|
6,418.09%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/29/18
|
6/27/19
|
4/27/20
|
4/29/21
|
4/18/22
|
4/24/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
170
|
91.5
|
509
|
808
|
858
|
151
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.2011
x
|
-0.3788
x
|
14.6
x
|
5.317
x
|
4.241
x
|
1.108
x
|
Free Cash Flow
1 |
366
|
263
|
45.6
|
-236
|
10.9
|
713
|
ROE (net income / shareholders' equity)
|
-171%
|
233%
|
-11.9%
|
67.8%
|
37.8%
|
8.09%
|
ROA (Net income/ Total Assets)
|
-45.7%
|
-66.3%
|
2.41%
|
3.63%
|
5.54%
|
2.86%
|
Assets
1 |
2,467
|
751.1
|
1,080
|
1,255
|
755.8
|
388.1
|
Book Value Per Share
2 |
0.0300
|
-0.4300
|
0.0400
|
0.0800
|
0.1200
|
0.1300
|
Cash Flow per Share
2 |
0
|
0.0100
|
0.0700
|
0.1000
|
0.1100
|
0.0700
|
Capex
1 |
0.7
|
-
|
2.26
|
12.3
|
39.4
|
7.81
|
Capex / Sales
|
2.29%
|
-
|
1.13%
|
1.14%
|
2.82%
|
0.57%
|
Announcement Date
|
8/29/18
|
6/27/19
|
4/27/20
|
4/29/21
|
4/18/22
|
4/24/23
|
|
1st Jan change
|
Capi.
|
---|
| -45.47% | 529M | | +4.70% | 103B | | +2.40% | 65.6B | | +42.86% | 39.06B | | +16.96% | 37.58B | | +6.96% | 33.26B | | +7.89% | 19.22B | | +12.12% | 16.83B | | +12.08% | 15.03B | | +17.69% | 14.96B |
Other Commodity Chemicals
|